Option chain shows key data for Dare Bioscience's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Dare Bioscience.

Dare Bioscience (NASDAQ:DARE) Stock, Option Chain

Dare Bioscience

Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Movers

News

Intraday Update

Markets

AGRI

AKAN

ALLO

AONC

APLD

ATEN

AULT

BDRX

BRSH

CRKN

CSLR

CTNT

DARE

EDBL

FFIE

FWRD

GSX Techedu Inc. American Depositary Shares

GOTU

GWAV

HSAI

ISUN

KEYS

LICN

Larimar Therapeutics, Inc. - Common Stock

LRMR

LUXH

MGOL

MGRX

MMAT

Eaton Vance Massachusetts Municipal Income Trust

NDSN

ONFO

PANW

PEGY

PTON

SCPX

TRNS

WALD

XPEV

XYLO

ZENV

Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Word,Menopause,,Pause,Sign,On,A,White,Alarm,Clock,On

Biotech

Large Cap

Health Care

General

ALPMF

BAYRY

BAYZF

Bayer to present detailed Phase 3 OASIS 1 and 2 study results showing elinzanetant significantly reduces moderate to severe menopausal vasomotor symptoms compared to placebo.

Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval

Image45

ADXN

AGBA

AKLI

ARCB

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BLND

CECO

CETX

CHGG

COUR

CYCC

EGOX

ELYM

ETWO

FFIV

GEHC

HEES

HLIT

MIND

MRIN

MSTR

MULN

NIVF

NRXP

RMBS

SGBX

SWVL

TREE

UAVS

VNCE

YUMC

Why H&amp;E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Dare Bioscience Inc

Press Releases

Daré Bioscience Selected to Receive $10 Million Award from ARPA-H's Sprint for Women's Health

Daré Bioscience to Host Third Quarter 2024 Financial Results and Company Update Conference Call and Webcast on November 14, 2024

Daré Bioscience Announces Grant to Support Development of a Novel Non-Hormonal Contraceptive Candidate and Expansion of Ovaprene® Pivotal Study Clinical Trial Sites

Earnings

Daré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company Update

Financing

Daré Bioscience Announces $2.5 Million Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1

Daré Bioscience Announces Publication in Sexual Medicine of Positive Findings from Demographic, Behavioral and Medication Use Subgroup Analyses in the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6%

Daré Bioscience Announces Phase 3 Plans for Sildenafil Cream, 3.6%, in the Treatment of Female Sexual Arousal Disorder (FSAD)

Daré Bioscience to Participate in the Women's Health Series at the 43rd Annual J.P. Morgan Healthcare Conference

Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development

Daré Bioscience and Theramex Announce Co-Development and Licensing Agreement for a Potential Biodegradable Long-Acting Contraceptive Implant

Anebulo Pharmaceuticals, Inc. - Common Stock

Anebulo Pharmaceuticals

AN2 Therapeutics

Athira Pharma

CalciMedica

Cara Therapeutics

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Cocrystal Pharma

Citius Pharmaceuticals, Inc. - Common Stock

Citius Pharmaceuticals

Cadrenal Therapeutics, Inc. - Common Stock

Cadrenal Therapeutics

Durect

Gelteq

Grace Therapeutics

Impact BioMedical

IGC Pharma

Opus Genetics

Iterum Therapeutics

Jupiter Neurosciences, Inc. - Common Stock

Jupiter Neurosciences

Lexaria Bioscience

Lipocine

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

NRX Pharmaceuticals

Pulmatrix

Scilex Holding

SCYNEXIS

VYNE Therapeutics

HC Wainwright & Co.

Jones Trading

Brookline Capital

JonesTrading

Comments

Dare Bioscience

Dare Bioscience (DARE) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga